FDA Approves IXEMPRA for the Treatment of Advanced Breast Cancer

Armen Hareyan's picture
Advertisement

Ixempra for breast cancer treatment

Bristol-Myers Squibb Company (NYSE: BMY) announced today that the U.S. Food and Drug Administration (FDA) has granted approval of IXEMPRA

Advertisement